• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

A no-go for aspirin, Vegetarian victory, Opioids and dementia +2: The Five for Friday


No aspirin for healthy elders, Vegan diets vs CVD, Opioids deadly in dementia, plus BP patterns in babies, and the fear of Alzheimer's runs deep.

Our editors' summaries of the 5 most newsworthy topics reported on Patient Care®this week.

©Burlingham/Shutterstock  Low-Dose Aspirin Increases Risk of Bleeding but Does Not Reduce Risk of a First Stroke in Older Adults

Aspirin a no-go for grandma. In healthy adults older than age 70 years the go-to antiplatelet for CVD prevention increased risk for bleeding but did not decrease the risk of a first stroke. The findings come from a new analysis of the largest RCT of daily low-dose (100 mg) aspirin to evaluate the risk/benefit ratio in older adults and bolsters the most recent recommendation from the USPSTF against routine use of the OTC drug for primary prevention of CVD. More details, here.

©Steve Heap/Shutterstock.com  First Opioid Use in Older Adults with Dementia Significantly Increased Mortality Risk

Opioids + dementia = deadly. After a diagnosis of dementia, a first opioid prescription was associated with significant increased risk for mortality, the highest risk occurring within the first 2 weeks of redeeming the prescription when Danish investigators observed a more than 10-fold increase in deaths. A more than 2-fold risk persisted at 90 days. Among those who received a first opioid prescription for fentanyl, 65.3% died within 180 days. More details, here.

©tan4likk/Adobe Stock Vegetarian Diet May Augment Effects of Optimal Drug Therapy in Patients at High Risk of CVD

Vegetarian victory. The dietary pattern, including lacto-ovo and lacto-vegetarian versions, was associated with modest, yet significant improvements in cardiometabolic risk factors on top of outcomes with standard pharmacologic treatment in people with or at high risk for CVD. A new meta-analysis found that, consumed for at least 6 months, a vegetarian diet led to significant reductions in LDL-C, HbA1c, and body weight in a highly vulnerable population. More details, here.

©Cappifrutta/Shutterstock  Distinct Patterns of BP in Early Gestation Predict Hypertensive Disorders: Study

BP patterns and babies. Investigators identified 6 blood pressure patterns that, when combined with other risk factors, accurately stratified risk of hypertensive disorders of pregnancy in the first 20 weeks of gestation. The predictive ability was consistent regardless of a pregnant person's race/ethnicity. Study authors say findings suggest that there are subsets of vulnerable patients even within populations at low-to-moderate risk. More details here.

©Andrey Popov/stock.adobe.com Cognitive Screening in Older Adults: How they Perceive the Benefits, What they Fear Most

Elders fear AD. Less than half of people aged 65 to 80 years who have a family history of dementia report having undergone cognitive screening in the past year. Less than one-quarter of this population have ever been screened. How others would perceive them if they tested positive for cognitive decline was a significant concern for many and particularly for women. More details, here.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2024 MJH Life Sciences

All rights reserved.